MedPath

CAP48 - Autism in Children and Adolescents

Recruiting
Conditions
Autism Spectrum Disorder
Registration Number
NCT06149468
Lead Sponsor
Université Catholique de Louvain
Brief Summary

Evaluation and follow-up of children diagnosed with an autism spectrum disorder in French-speaking Belgium in order to optimize diagnostic protocols, the quality of care required and its accessibility, and to determine the impact of an autism spectrum disorder on schooling, family and society.

Detailed Description

The aims of the research project:

* To collect a wide range of data in order to improve knowledge of children with autism spectrum disorder (ASD) in French-speaking Belgium by prospectively including all children and adolescents making a request to the centres of reference. The creation of a common database will make it possible to collect general socio-demographic, geographical and epidemiological data, to characterise the different profiles and to accurately monitor developmental trajectories.

* Evaluate the feasibility and practical implementation of the treatment proposed following a diagnosis of ASD in a child.

* Implement protocols to improve the quality of care for beneficiaries.

* To enable the development of fundamental research protocols. Many questions remain unanswered about the genetic, neuro-cognitive and linguistic characteristics of autism. Only rigorous studies carried out on large, carefully defined samples can advance research.

* Increase public knowledge and understanding of the ASD.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center from French-speaking region of Belgium.
Exclusion Criteria
  • refusal by the family to allow their child's data to be included in the database.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Creation of an ADS registerThroughout the entire study, approximately during 5 years

creation of a common ASD register to collect general sociodemographic, geographic and epidemiological data, characterize the different patient profiles and accurately track development trajectories

Secondary Outcome Measures
NameTimeMethod
Schooling evaluationThroughout the entire study, approximately during 5 years

Evaluate the schooling of children with ASD of all ages

Protocols developmentThroughout the entire study, approximately during 5 years

Enable the development of fundamental research protocols: genetic, neurocognitive and linguistic

Feasability assessmentThroughout the entire study, approximately during 5 years

Evaluate the feasibility and practical realization of the proposed care following a diagnosis of ASD in a child and implement protocols to improve the quality of therapy.

Trial Locations

Locations (1)

UCLouvain

🇧🇪

Bruxelles, Belgium

UCLouvain
🇧🇪Bruxelles, Belgium
Marie-Cécile Nassogne, Prof
Contact
02 764 1061
marie-cecile.nassogne@saintluc.uclouvain.be
Marine Houssa, PhD
Contact
010474688
marine.houssa@uclouvain.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.